Potassium Ion

SCHEMBL5807703

N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.N#CCOP(=O)(O)O.[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1 DHFR GABBR1 GABBR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 GABRB1 GABRB2 GABRB3 GABRD GABRE GABRG1 GABRG2 GABRG3 GABRP GABRQ GART NR3C2 PBP2X PTGS1 PTGS2 VKORC1 bla blaT-3 blaT-4 blaT-5 blaT-6 dacA dacB dacC folA ftsI mrcA mrcB mrdA pbp1a pbp1b pbp2a pbp2b pbp3 pol thyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	TPI1	P60174	2/20	0.34

▸	LPAR3	Q9UBY5	4/20	0.33

▸	LPAR2	Q9HBW0	3/20	0.33

▸	LPAR1	Q92633	2/20	0.33

▸	PGK1	P00558	1/20	0.33

▸	PGK2	P07205	1/20	0.33

▸	FBP1	P09467	1/20	0.32

▸	FDPS	P14324	1/20	0.32

▸	BLM	P54132	1/20	0.32

▸	TDP1	Q9NUW8	1/20	0.32

▸	PGD	P52209	2/20	0.31

▸	MPI	P34949	1/20	0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL4670278	0.97	—	—
Phosphoric Acid SCHEMBL7714297	0.95	TPI1 (0.34)	TPI1LPAR3LPAR2LPAR1PGK1
Ammonia Solution, Strong SCHEMBL10847788	0.95	TPI1 (0.34)	TPI1LPAR3LPAR2LPAR1PGK1
Ammonia Solution, Strong SCHEMBL4523855	0.95	TPI1 (0.34)	TPI1LPAR3LPAR2LPAR1PGK1
Ammonia Solution, Strong SCHEMBL3330065	0.95	—	—
SCHEMBL6794240	0.95	TPI1 (0.34)	TPI1LPAR3LPAR2LPAR1PGK1
Potassium Ion SCHEMBL5803916	0.89	SLC34A1 (0.32)	—
SCHEMBL4892596	0.83	LPAR3 (0.35)	LPAR3LPAR2LPAR1FBP1FDPS
Potassium Ion SCHEMBL5689772	0.80	—	—
Butylamine SCHEMBL9405028	0.78	LPAR3 (0.44)	LPAR3LPAR2LPAR1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2006115286-A1	PIPERIDINE DERIVATIVES, CRYSTAL, PROCESS FOR PRODUCING THE SAME, AND USE AS TACHIKININ RECEPTOR ANTAGONISTS	TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP)	2006-11-02	—	—	WO	disclosed
US-20060241145-A1	Piperidine derivative crystal, process for producing the same, and use	TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP)	2006-10-26	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20060241145-A1	Piperidine derivative crystal, process for producing the same, and use	PKD2, PKD1, TACR1	TPI1 3225/4885LPAR3 152/4885LPAR2 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.